LABZIENT

Serial Number 98660690
688

Registration Progress

Application Filed
Jul 22, 2024
Under Examination
Aug 26, 2025
Approved for Publication
Jul 1, 2025
Published for Opposition
Jul 1, 2025
Registered

Attorney Assistance

NOA E-Mailed - SOU Required
Due: Feb 26, 2026 116 days

Trademark Image

LABZIENT

Basic Information

Serial Number
98660690
Filing Date
July 22, 2024
Published for Opposition
July 1, 2025
Drawing Code
4

Status Summary

Current Status
Active
Status Code
688
Status Date
Aug 26, 2025
Application
Pending
Classes
042

Rights Holder

Abzena (UK) Limited

24
Address
Babraham Research Campus
Babraham, Cambridge CB223AT
GB

Ownership History

Abzena (UK) Limited

Original Applicant
24
Babraham, Cambridge GB

Abzena (UK) Limited

Owner at Publication
24
Babraham, Cambridge GB

Legal Representation

Attorney
Patricia I. Reding

USPTO Deadlines

Next Deadline
116 days remaining
NOA E-Mailed - SOU Required
Due Date
February 26, 2026
Extension Available
Until August 26, 2026

Application History

14 events
Date Code Type Description Documents
Aug 26, 2025 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Jul 1, 2025 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Jul 1, 2025 PUBO A PUBLISHED FOR OPPOSITION Loading...
Jun 25, 2025 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
May 29, 2025 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Apr 23, 2025 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Apr 23, 2025 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Apr 23, 2025 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Feb 3, 2025 CNRT R NON-FINAL ACTION WRITTEN Loading...
Feb 3, 2025 GNRT F NON-FINAL ACTION E-MAILED Loading...
Feb 3, 2025 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Jan 30, 2025 DOCK D ASSIGNED TO EXAMINER Loading...
Jan 15, 2025 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Jul 22, 2024 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 042
Scientific and technological services, namely, scientific research in the field of cell lines, cell cultures, proteins, and antibodies for use in the development and manufacture of vaccines and pharmaceutical preparations; industrial analysis and research in the field of cell lines, cell cultures, proteins, and antibodies for use in the development and manufacture of vaccines and pharmaceutical preparations; new product design services; pharmaceutical research services; pharmaceutical product evaluation; inspection of pharmaceuticals; testing of pharmaceuticals; pharmaceutical drug development services; development of pharmaceutical preparations and medicines; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; provision of scientific information in the field of vaccines, pharmaceuticals, and in the field of cell lines, proteins, and antibodies for use in the manufacture and development of pharmaceuticals and vaccines; provision of toxicological research information; toxicology research services, namely, assessing toxicological information in relation to risks; chemical research, namely, assessing chemical information in relation to risks; none of the aforementioned services relating to finished pharmaceutical products administered to patients for the treatment of Parkinson's disease or other diseases or disorders of the central nervous system

Classification

International Classes
042